We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID-19 infection in NMO/SD patients: a French survey.
- Authors
Zeidan, Sinéad; Maillart, Elisabeth; Louapre, Céline; Roux, Thomas; Lubetzki, Catherine; Papeix, Caroline
- Abstract
Keywords: NMOSD; COVID-19; Immunosuppressants; AQP4 EN NMOSD COVID-19 Immunosuppressants AQP4 1188 1190 3 03/26/21 20210401 NES 210401 Dear Sirs, COVID-19 pandemic due to SARS-CoV2 virus is ongoing, with a fatality rate around 5.4% [[1]]. Consistently with a French cohort study on MS patients [[13]], this survey is reassuring about the risk of severe COVID-19 in NMO/SD-immunosuppressed patients and supports the maintenance of immunosuppressive treatments for NMO/SD during COVID-19 pandemic. The aim of this case-series study is to describe the prevalence and characteristics of COVID-19 in NMO/SD patients.
- Subjects
COVID-19; PATIENT surveys; LYMPHOPENIA; COVID-19 pandemic; NEUROMYELITIS optica; SLEEP apnea syndromes; COMPUTED tomography
- Publication
Journal of Neurology, 2021, Vol 268, Issue 4, p1188
- ISSN
0340-5354
- Publication type
Letter
- DOI
10.1007/s00415-020-10112-1